Tandem Diabetes Care logo

Tandem Diabetes CareNASDAQ: TNDM

Profile

Sector:

Healthcare

Country:

United States

IPO:

14 November 2013

Next earnings report:

21 February 2025

Last dividends:

N/A

Next dividends:

N/A
$1.84 B
-81%vs. 3y high
80%vs. sector
-vs. 3y high
-vs. sector
-69%vs. 3y high
90%vs. sector
-85%vs. 3y high
40%vs. sector

Price

after hours | Fri, 15 Nov 2024 23:40:29 GMT
$28.00-$0.55(-1.93%)

Dividend

No data over the past 3 years
$243.97 M$251.50 M
$243.97 M-$23.25 M

Analysts recommendations

Institutional Ownership

TNDM Latest News

TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket
zacks.com08 November 2024 Sentiment: POSITIVE

Tandem Diabetes' top and bottom lines outpace estimates in the third quarter, backed by the demand for both t:slim X2 and the newly launched Tandem Mobi.

Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say
zacks.com06 November 2024 Sentiment: POSITIVE

While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Why Tandem Diabetes Care Stock Took It on the Chin Tuesday
fool.com01 October 2024 Sentiment: NEGATIVE

Flat revenue growth might be in store for the company in a very crucial market.

t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock
zacks.com01 October 2024 Sentiment: POSITIVE

By integrating ultra-rapid acting insulin such as Lyumjev, which responds faster than traditional insulin, Tandem Diabetes Care is enhancing the pump's functionality.

TNDM Stock Likely to Gain From Innovation Amid Competition
zacks.com23 September 2024 Sentiment: POSITIVE

Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for people living with the condition.

TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU
zacks.com23 September 2024 Sentiment: POSITIVE

Tandem Diabetes' t:slim X2 insulin pump is now compatible with Lilly's Lyumjev in the European Union.

Reasons to Hold Tandem Diabetes Stock in Your Portfolio Now
zacks.com03 September 2024 Sentiment: POSITIVE

Innovations and a robust diabetes market outlook raise investors' optimism for TNDM.

New Launches Support Tandem Diabetes Stock Despite Macro Concerns
zacks.com30 August 2024 Sentiment: POSITIVE

The latest addition to TNDM's pump platform portfolio, Tandem Mobi, is leading the way in creating a whole new category of devices for insulin therapy.

Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall
businesswire.com19 August 2024 Sentiment: NEUTRAL

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) today announced the planned release of version 2.8.2 of its Apple iOS t:connect mobile app in the United States on August 20, 2024 to correct an issue described in a March 2024 recall that can cause rapid depletion of a user's t:slim X2 insulin pump battery. This battery depletion can result in the pump shutting down sooner than expected, which some customers have continued to see following the release of version 2.7.1 of the.

Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say
zacks.com01 August 2024 Sentiment: POSITIVE

While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

What type of business is Tandem Diabetes Care?

Tandem Diabetes Care, Inc. is a company that designs, manufactures, and commercializes medical devices for insulin therapy. Founded in 2006, the company is headquartered and has manufacturing facilities in San Diego, California. The company's activities are fully focused on the flagship pump platform - the t:slim X2 insulin delivery system and additional product offerings. The t:slim X2 hardware platform is the only commercial insulin pump that allows users to quickly and easily update their pump software from a personal computer. In addition to Tandem insulin pumps, the company sells disposable products or consumables - insulin storage and delivery cartridges and infusion sets.

What sector is Tandem Diabetes Care in?

Tandem Diabetes Care is in the Healthcare sector

What industry is Tandem Diabetes Care in?

Tandem Diabetes Care is in the Medical Devices industry

What country is Tandem Diabetes Care from?

Tandem Diabetes Care is headquartered in United States

When did Tandem Diabetes Care go public?

Tandem Diabetes Care initial public offering (IPO) was on 14 November 2013

What is Tandem Diabetes Care website?

https://www.tandemdiabetes.com

Is Tandem Diabetes Care in the S&P 500?

No, Tandem Diabetes Care is not included in the S&P 500 index

Is Tandem Diabetes Care in the NASDAQ 100?

No, Tandem Diabetes Care is not included in the NASDAQ 100 index

Is Tandem Diabetes Care in the Dow Jones?

No, Tandem Diabetes Care is not included in the Dow Jones index

When was Tandem Diabetes Care the previous earnings report?

No data

When does Tandem Diabetes Care earnings report?

The next expected earnings date for Tandem Diabetes Care is 21 February 2025